These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
118 related items for PubMed ID: 8174206
1. Weekly 5-fluorouracil and high-dose folinic acid in combination with epidoxorubicin as first-line therapy in advanced breast cancer: a phase II study. Stöger H, Bauernhofer T, Kasparek AK, Schmid M, Moser R, Ploner F, Derstvenscheg E, Kuss I, Wilders-Truschnig M, Steindorfer P. Cancer Chemother Pharmacol; 1994; 34(1):75-8. PubMed ID: 8174206 [Abstract] [Full Text] [Related]
2. A phase II trial of weekly high-dose folinic acid and 5-fluorouracil in combination with epirubicin as salvage chemotherapy in advanced breast cancer. Stöger H, Schmid M, Bauernhofer T, Moser R, Ploner F, Derstvenscheg E, Kasparek AK, Kuss I, Wilders-Truschnig M, Lackner C. Oncology; 1994; 51(6):518-22. PubMed ID: 7970497 [Abstract] [Full Text] [Related]
3. A phase I/II study of 4'-O-tetrahydropyranyl-doxorubicin, 5-fluorouracil, and high-dose leucovorin as first-line therapy in advanced breast cancer patients. Stöger H, Bauernhofer T, Schmid M, Ploner F, Moser R, Derstvenscheg E, Steindorfer P, Wilders-Truschnig M, Kuss I, Samonigg H. Cancer Chemother Pharmacol; 1994; 35(2):174-8. PubMed ID: 7987997 [Abstract] [Full Text] [Related]
6. Phase I/II study with paclitaxel in combination with weekly high-dose 5-fluorouracil/folinic acid in the treatment of metastatic breast cancer: an interim analysis. Klaassen U, Wilke H, Pari CP, Strumberg D, Harstrick A, Eberhardt W, Becher R, Diergarten K, Seeber S. Semin Oncol; 1995 Dec; 22(6 Suppl 14):7-11. PubMed ID: 8553083 [Abstract] [Full Text] [Related]
7. Phase I-II study of vinorelbine in combination with 5-fluorouracil and folinic acid as first-line chemotherapy in metastatic breast cancer: a regimen with a low subjective toxic burden. Nolè F, de Braud F, Aapro M, Minchella I, De Pas TM, Zampino MG, Monti S, Andreoni G, Goldhirsch A. Ann Oncol; 1997 Sep; 8(9):865-70. PubMed ID: 9358936 [Abstract] [Full Text] [Related]
8. Phase II study of weekly mitoxantrone, 5-fluorouracil, and leucovorin in metastatic breast cancer. Repetto L, Miglietta L, Gardin G, Lanfranco C, Naso C, Merlini L, Giudici S, Venturino A, Campora E, Testore F. Breast Cancer Res Treat; 1994 Sep; 30(2):133-7. PubMed ID: 7949211 [Abstract] [Full Text] [Related]
11. Weekly high-dose leucovorin versus low-dose leucovorin combined with fluorouracil in advanced colorectal cancer: results of a randomized multicenter trial. Study Group for Palliative Treatment of Metastatic Colorectal Cancer Study Protocol 1. Jäger E, Heike M, Bernhard H, Klein O, Bernhard G, Lautz D, Michaelis J, Meyer zum Büschenfelde KH, Knuth A. J Clin Oncol; 1996 Aug; 14(8):2274-9. PubMed ID: 8708717 [Abstract] [Full Text] [Related]
14. A phase II study of irinotecan alternated with a weekly schedule of oxaliplatin, high-dose leucovorin and 48-hour infusion 5-fluorouracil in patients with advanced colorectal cancer. Rosati G, Tucci A, Rinaldi A, Colarusso D, Pizza C, Reggiardo G, Manzione L. Oncology; 2004 Aug; 66(5):371-8. PubMed ID: 15331924 [Abstract] [Full Text] [Related]
15. Treatment of advanced breast cancer with 5-fluorouracil and high-dose folinic acid: preliminary results. Marini G, Marpicati P, Zaniboni A, Cervi GC, Gorni F, Simoncini E. Chemioterapia; 1985 Apr; 4(2):135-8. PubMed ID: 3874000 [Abstract] [Full Text] [Related]
16. Weekly high-dose infusional 5-fluorouracil (HD-5-FU) combinations in the treatment of advanced breast cancer: results of phase I/II studies with weekly 24-hour infusion of HD-5-FU plus high-dose folinic acid (FA) alone and in combination with paclitaxel and cisplatin. Klaassen U, Wilke H, Seeber S. J Infus Chemother; 1996 Apr; 6(3):127-32. PubMed ID: 9229323 [Abstract] [Full Text] [Related]
17. A phase I-II study of cyclophosphamide, epidoxorubicin, levofolinic acid/5-fluorouracil and recombinant human granulocyte colony stimulating factor in metastatic breast carcinoma. Callari A, Gebbia V, Testa A, Cusimano MP, Cipolla C, Amato C, Cannata G, Latteri MA, Garascia C, Gebbia N. Acta Oncol; 1994 Apr; 33(8):925-9. PubMed ID: 7529516 [Abstract] [Full Text] [Related]
18. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.). Gebbia V, Majello E, Testa A, Pezzella G, Giuseppe S, Giotta F, Riccardi F, Fortunato S, Colucci G, Gebbia N. Cancer; 1996 Sep 15; 78(6):1300-7. PubMed ID: 8826954 [Abstract] [Full Text] [Related]
19. Preclinical and clinical study results of the combination of paclitaxel and 5-fluorouracil/folinic acid in the treatment of metastatic breast cancer. Klaassen U, Harstrick A, Wilke H, Seeber S. Semin Oncol; 1996 Feb 15; 23(1 Suppl 1):44-7. PubMed ID: 8629037 [Abstract] [Full Text] [Related]
20. Epidoxorubicin and double biochemical 5-fluorouracil modulation with folinic acid and human lymphoblastoid interferon in advanced gastric carcinoma: a multicentric phase II study of the Southern Italy Oncology Group (GOIM). Colucci G, Maiello E, Gebbia V, Cifarelli RA, Biglietto M, Pedicini A, Durini E, Giuliani F, Gebbia N. Oncology; 1996 Feb 15; 53(4):269-74. PubMed ID: 8692529 [Abstract] [Full Text] [Related] Page: [Next] [New Search]